Published in Clin Infect Dis on April 12, 2005
Colitis due to Clostridium difficile toxins: underdiagnosed, highly virulent, and nosocomial. Proc (Bayl Univ Med Cent) (2006) 2.26
Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection. Antibiotics (Basel) (2015) 0.86
Amphotericin B: time for a new "gold standard". Clin Infect Dis (2003) 4.01
Structural engineering of a phage lysin that targets gram-negative pathogens. Proc Natl Acad Sci U S A (2012) 2.36
Treatment and prevention of urinary tract infection with orally active FimH inhibitors. Sci Transl Med (2011) 2.16
Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection. Sci Transl Med (2013) 1.88
The siderophore yersiniabactin binds copper to protect pathogens during infection. Nat Chem Biol (2012) 1.68
Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection. Blood (2012) 1.68
Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California. J Clin Microbiol (2006) 1.65
A central metabolic circuit controlled by QseC in pathogenic Escherichia coli. Mol Microbiol (2011) 1.26
Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent clostridium difficile-associated diarrhea. J Clin Microbiol (2003) 1.19
Escherichia coli biofilms have an organized and complex extracellular matrix structure. MBio (2013) 1.17
Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile. Clin Infect Dis (2012) 1.11
Spatial and temporal analysis of Clostridium difficile infection in patients at a pediatric hospital in California. Infect Control Hosp Epidemiol (2005) 1.11
Evaluation of Clostridium difficile fecal load and limit of detection during a prospective comparison of two molecular tests, the illumigene C. difficile and Xpert C. difficile/Epi tests. J Clin Microbiol (2012) 1.07
Both host and pathogen factors predispose to Escherichia coli urinary-source bacteremia in hospitalized patients. Clin Infect Dis (2012) 1.05
Lead optimization studies on FimH antagonists: discovery of potent and orally bioavailable ortho-substituted biphenyl mannosides. J Med Chem (2012) 1.05
Outcomes in patients tested for Clostridium difficile toxins. Diagn Microbiol Infect Dis (2012) 1.03
Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice. Antimicrob Agents Chemother (2012) 1.02
Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile. J Med Microbiol (2008) 1.02
Cupric yersiniabactin is a virulence-associated superoxide dismutase mimic. ACS Chem Biol (2013) 1.01
Epidemiologic surveillance of Clostridium difficile diarrhea in a freestanding pediatric hospital and a pediatric hospital at a university medical center. Diagn Microbiol Infect Dis (2006) 0.96
Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: an assessment of currently available triazoles. Antimicrob Agents Chemother (2011) 0.94
Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile. J Antimicrob Chemother (2003) 0.94
Direct tests of enzymatic heme degradation by the malaria parasite Plasmodium falciparum. J Biol Chem (2012) 0.93
Development of an integrated metabolomic profiling approach for infectious diseases research. Analyst (2011) 0.92
Early treatment with fluconazole may abrogate the development of IgG antibodies in coccidioidomycosis. Clin Infect Dis (2011) 0.91
Treatments for hepatitis B. Clin Infect Dis (2004) 0.88
Metabolomic analysis of siderophore cheater mutants reveals metabolic costs of expression in uropathogenic Escherichia coli. J Proteome Res (2014) 0.87
Parathyroid hormone-related protein ameliorates death receptor-mediated apoptosis in lung cancer cells. Am J Physiol Cell Physiol (2003) 0.86
Antimicrobial phenotypes and molecular basis in clinical strains of Clostridium difficile. Diagn Microbiol Infect Dis (2007) 0.86
Derivation and validation of a clinical prediction score for isolation of inpatients with suspected pulmonary tuberculosis. Infect Control Hosp Epidemiol (2008) 0.86
Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli. J Antimicrob Chemother (2004) 0.86
High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin. J Subst Abuse Treat (2010) 0.85
Clindamycin resistant strains of Clostridium difficile isolated from cases of C. difficile associated diarrhea (CDAD) in a hospital in Sweden. Diagn Microbiol Infect Dis (2002) 0.85
Hepatic mucormycosis with abscess formation. Diagn Microbiol Infect Dis (2012) 0.85
OPT-80, a macrocyclic antimicrobial agent for the treatment of Clostridium difficile infections: a review. Expert Opin Investig Drugs (2008) 0.84
Yersinia high pathogenicity island genes modify the Escherichia coli primary metabolome independently of siderophore production. J Proteome Res (2011) 0.83
Isolation of non-toxigenic strains of Clostridium difficile from cases of diarrhea among patients hospitalized in hematology/oncology ward. Pol J Microbiol (2004) 0.83
Analysis of Clostridium difficile-associated diarrhea among patients hospitalized in tertiary care academic hospital. Diagn Microbiol Infect Dis (2005) 0.83
Injecting drug use and community-associated methicillin-resistant Staphylococcus aureus infection. Diagn Microbiol Infect Dis (2008) 0.83
Parathyroid hormone-related protein regulates apoptosis in lung cancer cells through protein kinase A. Am J Physiol Cell Physiol (2004) 0.83
Serum (1->3)-β-D-glucan measurement in coccidioidomycosis. J Clin Microbiol (2012) 0.83
Metal selectivity by the virulence-associated yersiniabactin metallophore system. Metallomics (2015) 0.82
In vitro activity of linezolid against Clostridium difficile. J Antimicrob Chemother (2003) 0.82
The continuing saga of MRSA. J Infect Dis (2008) 0.82
Identification and quantification of mutagenic halogenated cytosines by gas chromatography, fast atom bombardment, and electrospray ionization tandem mass spectrometry. Anal Biochem (2003) 0.80
Prevalence of enterotoxigenic Bacteroides fragilis in hospital-acquired diarrhea. Diagn Microbiol Infect Dis (2006) 0.80
Vaccines, viruses, and voodoo. J Investig Allergol Clin Immunol (2002) 0.79
Clostridium difficile in emergency room. Anaerobe (2005) 0.78
Association between serum 25-hydroxyvitamin D level and type of coccidioidal infection. Med Mycol (2012) 0.77
Patient characteristics but not virulence factors discriminate between asymptomatic and symptomatic E. coli bacteriuria in the hospital. BMC Infect Dis (2013) 0.77
8-Nitroxanthine, a product of myeloperoxidase, peroxynitrite, and activated human neutrophils, enhances generation of superoxide by xanthine oxidase. Arch Biochem Biophys (2003) 0.76
Not all nosocomial Escherichia coli bacteriurias are catheter associated. Infect Control Hosp Epidemiol (2011) 0.75
Coccidioidomycosis: adenosine deaminase levels, serologic parameters, culture results, and polymerase chain reaction testing in pleural fluid. Chest (2013) 0.75
Co-infection of hamsters with toxin A or toxin B-deficient Clostridium difficile strains. Pol J Microbiol (2005) 0.75
Treatment of cytomegalovirus retinitis with cytomegalovirus-specific T-lymphocyte infusion. Ophthalmic Surg Lasers Imaging Retina (2015) 0.75
Therapeutic efficacy of moxifloxacin in a murine model of severe systemic mixed infection with Escherichia coli and Bacteroides fragilis. Anaerobe (2003) 0.75
Teaching neuroimages: fungus in the brain: coccidioidomycosis meningoencephalitis. Neurology (2013) 0.75
Emerging concepts of biofilms in infectious diseases. Mo Med (2009) 0.75
Marked migration of sternotomy wires: a case report. J Thorac Imaging (2004) 0.75
Cutaneous manifestations of infection in returning travelers. Curr Infect Dis Rep (2014) 0.75